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Abstract
Recent evidence has demonstrated additional roles for the neuronal guidance protein receptor UNC5B outside the nervous
system. Given the fact that ischemia reperfusion injury (IRI) of the liver is a common source of liver dysfunction and the role of
UNC5B during an acute inflammatory response we investigated the role of UNC5B on acute hepatic IRI. We report here that
UNC5B
+/2 mice display reduced hepatic IRI and neutrophil (PMN) infiltration compared to WT controls. This correlated with
serumlevelsoflactate dehydrogenase(LDH),aspartate-(AST)andalanine-(ALT)aminotransferase,thepresenceofPMNwithin
ischemic hepatictissue,andserum levelsof inflammatory cytokines.Moreover,injectionof an anti-UNC5B antibodyresulted in
a significant reduction of hepatic IR injury. This was associated with reduced parameters of liver injury (LDH, ALT, AST) and
accumulation of PMN within the injured hepatic tissue. In conclusion our studies demonstrate a significant role for UNC5B in
the development of hepatic IRI and identified UNC5B as a potential drug target to prevent liver dysfunction in the future.
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Introduction
During several clinical conditions such as liver resection, liver
transplantation or generalized shock, ischemia-reperfusion injury
(IRI) is a common cause of liver dysfunction and hepatic failure [1].
Moreover hepatic IRI can contribute to the systemic inflammatory
response syndrome with subsequent multiple organ failure [2].
Various underlying mechanisms of hepatic IRI are well known,
including the induction of tissue necrosis, the generation of reactive
oxygenspecies[3],the releaseofproinflammatorycytokinesandthe
recruitment and activation of immunocompetent cells [4–6].
Notably, neutrophils play a key role in the development of hepatic
IRI [4,5]. Accumulation of neutrophils in the liver significantly
contributes to hepathocyte necrosis by release of proteolytic
enzymes and superoxide anions during hepatic IRI.
It is well established that activation and migration of leukocytes
is controlled through the chemokine system [7]. However recent
studies provide evidence that neuronal guidance proteins (NGP)
and their receptors display an alternative class of guidance cues in
the immune system that steer immune responses particularly with
regard to activation and migration of leukocytes [8,9]. NGP were
first identified in the developing central nervous system (CNS),
where neurons and axons are precisely guided to their final
location by a balance of chemoattractive and chemorepulsive
signals to establish the elaborate neuronal circuitry [10,11].
Several families of such conserved neuronal guidance cues
influencing axonal migration were identified to date. Recent data
provide evidence that the NGP receptor Uncoordinated-5
homolog B (UNC5B) holds additional function outside the nervous
system especially in the control of the immune system [12–16].
The NGP netrin-1, as endogenous ligand of UNC5B, has shown
potent anti-inflammatory properties in animal models of hypoxia,
ventilator associated lung injury, peritonitis and renal ischemia-
reperfusion injury [17]. Tadagavadi et al. showed that netrin-1
application protected against renal IRI. This effect was not present
after pre-treatment with an anti UNC5B antibody, suggesting that
the protective effects of netrin-1 were mediated through an
interaction with UNC5B.
Given clinical significance of hepatic IRI and the role of
UNC5B for the control of an immune response, we pursued its
role during hepatic IRI. For this we investigated the role of the
UNC5B receptor in a murine model of hepatic IRI. We show here
that UNC5B
+/2 mice present with reduced hepatic IRI. Moreover
functional inhibition of the UNC5B receptor with an UNC5B
antibody dampened the extent of hepatic IRI.
Methods
Mice
Heterozygous UNC5B
+/2 receptor knockout mice were kindly
provided by Dr. Tessier-Lavigne. UNC5B
+/2 mice were gener-
ated, validated and characterized as described previously [18].
UNC5B
+/2 mice and controls were selected to be similar in age
PLoS ONE | www.plosone.org 1 July 2012 | Volume 7 | Issue 7 | e41085(6–8 weeks), weight (20–25 g) and randomised in gender. All
animal experiments in this study are specifically approved by the
Regierungspra ¨sidium Tu ¨bingen and the local ethics committee of
the Tu ¨bingen University Hospital.
Murine model of hepatic ischemia reperfusion injury
Following the induction of anaesthesia mice were placed on a
heated table to maintain body temperature at 37uC. Midline
laparotomy with caudal mobilisation of the intestine was
Figure 1. UNC5B expression outside the CNS. A) Relative UNC5B mRNA expression in brain, heart, intestine, blood, lung, kidney, liver and
spleen in C57Bl/6 mice. B)–E) Flowcytometry of murine leukocytes gated and stained for the leukocyte marker CD45 (PerCP labeled), the macrophage
marker F4/80 (APC labeled) and UNC5B (PE labeled). F) Immune fluorescence staining of human PMN was performed using anti-UNC5B and CD45
antibodies as primary and Alexa488-conjugated and CruzFluor
TM 594-conjugated as secondary antibodies were used as well as isotype matched
control antibodies. (Data are mean 6 SEM, n=4 per condition).
doi:10.1371/journal.pone.0041085.g001
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+/2 animals demonstrate reduced hepatic IRI. WT and UNC5B
+/2 animals underwent 30 minutes ischemia and 3 hours of
reperfusion (IR) or sham operation before samples were taken. Serum was analysed for A) LDH, B) ALT, C) AST (Data are mean 6 SEM, n=6 per
condition). D) Representative pictures of TTC stained liver lobes are shown (n=4 per condition).
doi:10.1371/journal.pone.0041085.g002
Figure 3. UNC5B
+/2 animals display lowered systemic cytokine levels following hepatic IRI. Serum analysis of A) TNF-a, B) IL-6 and C) IL-
1b of WT and UNC5B
+/2 mice following IRI and sham operation are shown. Data are mean 6 SEM, n=6 per group.
doi:10.1371/journal.pone.0041085.g003
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ischemia was induced for 30 minutes by reversible occlusion of the
portal triad using a hanging-weight system as described previously
[19]. This was followed by a reperfusion phase of 3 hours before
animals were sacrificed and organs were harvested.
Quantification of the liver injury
Serum alanine- (ALT) and aspartate- (AST) aminotransferase
levels were measured with a colorimetric kit (Teco Diagnostics,
Anaheim, CA) as described previously [19]. Lactate dehydroge-
nase (LDH) activity in the serum was measured using a
photometric kit (Randox, Cumlin, UK).
Antibodies used
Functional inhibition of UNC5B was performed by i.v. injection
of anti-UNC5B antibody [17] (5 mg/mouse, R&D Systems, #
AF1006) 15 minutes prior to surgical procedures. Appropriate
isotype IgG was used as control.
Real time PCR
Real-time RT-PCR was performed by a StepOnePlus
TM
Real-time PCR system (Applied Biosystems, Foster City, CA) to
detect UNC5B, TNF-a, IL-6, CXCL1 and CXCL2 mRNA
levels using the following primers. UNC5B sense primer 59-
GGACCTCCT TCAGTGCTACA-39 and 59-GCTAAGTCC
TCATCCT-39 anti sense primer, TNF-a sense primer 59-
ACTCCAGGCGGTGCCTATGT-39 and 59-TCCAGCTGCT
CCTCCACTTG-39 anti sense primer, IL-6 sense primer 59-
ACCGCTATGAAGTTCCTCTC-39 and 59-CTCTCCGGA
CTTGTGAAGTA-39 anti sense primer, CXCL1 sense primer
59-TAGGAACCCCCTCCTCAGCCCA-39 and 59-AAGTCC-
GAACTCCCGGTGTGGT-39 anti sense primer, CXCL2
sense primer 59-TGGGGAAGGACATCCCAGGGTC-39 and
59-ACAGAGCCCCGCCCCTAAGC-39 anti sense primer.
Samples were normalized with b-actin using sense 59-GGTGG
CTTTTAGGATGGCAAG-39 and antisense 59-ACTGGAA
CG GTGAAGGTGACAG-39 primers.
Cytokine measurement
Serum levels of IL-1b,I L - 6a n dT N F - a,w e r em e a s u r e d
using a multiplex bead immunoassay kit (invitrogen
TM)i n
combination with a Luminex 100 system (Luminex corp.,
Austin, TX).
Figure 4. UNC5B
+/2 animals show reduced PMN infiltration and activity following hepatic IRI. A) PNM counts per high power field in WT
and UNC5B
+/2 mice in the stained liver tissue. B) Relative MPO activity in hepatic tissue of WT and UNC5B
+/2 animals C) Representative pictures of
PMN staining of liver lobes (brown, marked with arrowheads) of WT and UNC5B
+/2 mice after IRI and sham operation are shown (magnification
4006). Data are mean 6 SEM, n=6 per group.
doi:10.1371/journal.pone.0041085.g004
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Immunohistochemical staining of PMN was performed from
paraffin embedded tissue sections as described previously [20]. As
primary antibody a rat anti mouse Ly-6b.2 (AbD Serotec,
Du ¨sseldorf, Germany) and as secondary antibody a biotinylated
rabbit anti rat antibody (Vector Laboratories, Burlingame, CA)
was used. Isolated human PMN from peripheral blood were
stained as described previously [20]. Goat anti-UNC5B (Santa
Cruz Biotechnology) and mouse anti-human CD45 (Abcam,
clone: 0.N.125) antibodies as primary and Alexa488-conjugated
donkey anti-goat and CruzFluor
TM 594-conjugated donkey anti-
mouse (Santa Cruz Biotechnology) as secondary antibodies were
used.
FACS analysis
Collected heparinised mouse blood was incubated with eryth-
rocyte lysing solution for 5 minutes at room temperature. Cells
were washed and incubated with an PE labeled UNC5B antibody
(Abcam, Cambridge, UK, #ab54430), APC labeled F4/80
(eBioscience, San Diego, CA, #17480182), PerCp labeled CD45
antibody (BD Biosciences, Heidelberg, Germany, #557235) or
isotype matched control antibody lightproof for 1 hour at room
temperature. A BD FACS Canto
TM II flowcytometer was used to
perform FACS analysis employing BD FACS Diva
TM software.
Triphenyltetrazolium chloride staining (TTC)
Median liver lobes were extracted, placed on parafilm, frozen at
220uC for 30 min and cut into 1 mm slices. The slices were
incubated with 1% TTC at 37uC for 30 min and fixed in 10%
formalin.
Data analysis
All data are presented as mean 6 SEM. Statistical analysis was
performed with GraphPad 5.0 software (GraphPad, San Diego,
CA). For Multiple comparisons one-way ANOVA with Bonferroni
adjustment was performed and for single comparison the unpaired
Student’s t test was applied. A value of P ,0,05 was considered
significant.
Results
Expression pattern of UNC5B
To validate our model we first addressed the question whether
UNC5B is expressed in organs of C57Bl/6 mice outside the CNS.
Real time PCR showed that UNC5B mRNA is expressed within
several murine organs (Figure 1A). To specify the UNC5B
expression on immunocompetent cells we performed flowcytome-
try using CD45 as a general marker for leukocytes and F4/80 to
label macrophages. We found a robust signal for UNC5B on
neutrophil, macrophage and lymphocyte populations (Figure 1B–
E). This was confirmed by immunofluorescence staining of
leukocytes (Figure 1F).
Hepatic ischemia-reperfusion injury is reduced in
UNC5B
+/2 mice
To clarify the impact of UNC5B during hepatic IRI we used
previously characterised UNC5B
+/2 mice and C57BL/6 wild type
(WT) mice. Following hepatic IRI, UNC5B
+/2 mice displayed
significant reduced serum levels of LDH, ALT and AST compared
to WT animals (Figure 2A–C). TTC staining of injured liver lobes
further exemplified reduced hepatic IRI (Figure 2D). Moreover
Figure 5. Administration of an anti-UNC5B antibody reduces hepatic IRI. WT animals treated with an anti-UNC5B antibody or
Immunoglobulin (IgG) prior to the induction of IRI. A) LDH, B) ALT, C) AST in the serum was analysed (Data are mean 6 SEM, n=6 per condition). D)
Representative pictures of TTC stained liver lobes are shown (n=4 per condition).
doi:10.1371/journal.pone.0041085.g005
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C), were marked reduced in UNC5B
+/2 mice. The expression of
mRNA analysed from injured liver tissue revealed that TNF-a
expression was not significantly altered, whereas IL-6 was induced
in the injured liver tissue of WT but not in UNC5B
+/2 animals.
Furthermore we found that CXCL1 and CXCL2 are induced in
WT but not in UNC5B
+/2 animals after IRI (Figure S1). This was
accompanied by significant reduced infiltration of PMN into
affected liver lobes (Figure 4A and C) in UNC5B
+/2 mice and
confirmed by reduced MPO activity measured from the injured
liver tissue (Figure 4B).
Functional inhibition of UNC5B is protective during
hepatic ischemia-reperfusion injury
Finally we tested therapeutic potential of functional inhibition of
UNC5B in WT mice by injection of a blocking anti-UNC5B
antibody. Mice treated with the antibody showed significant
reduced serum levels of LDH, ALT and AST as compared with
control animals after hepatic IRI (Figure 5A–C). TTC staining of
liver lobes further confirmed these results (Figure 5D). This was
associated with significant reduced infiltration of PMN and MPO
activity measured in injured liver tissues (Figure 6A–C). Addition-
ally serum levels of the Cytokines TNF-a, IL-6 and IL-1b
(Figure 7A–C) were lower in the antibody treated group without
being significant.
Discussion
A functional role of the NGP Receptor UNC5B was first
described in the context of axonal guidance during CNS
development. Recent data have however also shown a role for
UNC5B in the immune system in particular during immune cell
adhesion, migration and the orchestration of an acute inflamma-
tory response. Since the pathophysiology of IRI underlies
mechanisms of sterile inflammation [21] and UNC5B is implicated
in these processes, it is not surprising that the UNC5B receptor is
critically involved in renal IRI [17]. We therefore hypothesize that
UNC5B might be of relevance during hepatic IRI. Thus we
investigated the role of UNC5B during hepatic ischemia followed
by reperfusion. We report here that UNC5B
+/2 mice showed
marked reduced hepatic IRI as measured by serum LDH, ALT
Figure 6. Anti-UNC5B antibody treatment diminishes hepatic
PMN infiltration following hepatic IRI. A) PNM counts per high
power field in the stained liver tissue. B) Relative hepatic MPO activity in
mice pre-treated wit anti-UNC5B or IgG control. C) Representative
pictures of histological PMN staining of liver lobes (brown, marked with
arrowheads) of WT mice pre-treated with anti-UNC5B or IgG after IRI,
are shown (magnification 4006). Data are mean 6 SEM, n=6 per
group.
doi:10.1371/journal.pone.0041085.g006
Figure 7. Functional inhibition of UNC5B trends to reduced systemic cytokine response after IRI. Serum of WT animals treated with anti-
UNC5B antibody or Immunoglobulin (IgG) analysed for A) TNF-a, B) IL-6 and C) IL-1b after IRI. Data are mean 6 SEM, n=6 per group.
doi:10.1371/journal.pone.0041085.g007
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systemic inflammatory response. Additionally, the infiltration of
neutrophils and their activity within the affected hepatic tissue was
diminished in UNC5B
+/2 mice. Moreover the pre-treatment of
WT mice with an anti-UNC5B antibody significantly dampened
liver injury, neutrophil infiltration and activity and trends to lower
systemic cytokine levels. As such we provide evidence that UNC5B
act as pro-inflammatory receptor during hepatic IRI and might
serve as potential drug target to prevent hepatic IRI in the future.
In Vertebrates UNC5B mediates chemorepellant properties of
the NGP netrin-1 during development of the CNS [22]. But
UNC5B is not only located in the CNS. To confirm previous
studies [9,17] we found robust UNC5B expression within heart,
lung, liver, intestine, spleen, blood, neutrophils, macrophages and
lymphocytes. This expression pattern suggests that UNC5B holds
function outside the CNS. And indeed UNC5B is implicated into
different processes such as angio- [18] and cancerogenesis [23] as
well as the control of acute inflammation [9] and IRI [17]. Loss of
UNC5B gene expression during angiogenesis yield to extended
endothelial tip cell filopodia, abnormal vessel branching and
navigation [18]. During cancerogenesis UNC5B is downregulated
in various kinds of tumor [23] affecting anchorage-independent
growth and invasiveness and cell survival. Evidentially UNC5B as
dependence receptor mediates p-53 induced apoptosis by its death
domain [24] which is cleaved off when netrin-1 is not bound to the
UNC5B receptor.
Since cell migration, adhesion and survival are critical
characteristics influencing acute inflammatory processes it might
be expected that UNC5B could be involved into the control of
inflammation and IRI. Concerning leukocyte migration properties
there is controversial data about the role of UNC5B. Recent
studies employing the UNC5B ligand netrin-1 [9,17] showed that
netrin-1 inhibits migration and infiltration of affected tissues by
immunocompetent cells like PMN and monocytes in UNC5B
dependent manner. Treatment with an anti-UNC5B antibody
abolished the effects of netrin-1 during fMLP-induced chemotaxis
in vitro [9] and renal ischemia reperfusion in vivo [17].
Additionally Mirakaj et al. [25] showed that the anti-inflammatory
effect of netrin-1 during Zymosan A induced Peritonitis is
mediated by the A2BAR receptor. This is supported by data of
Aherne et al. [26] who showed that UNC5B blockade was not
able to affect DSS induced Colitis but was A2BAR receptor
dependent. In contrast our data provides evidence that heterozy-
gous knock out and functional inhibition of UNC5B reduces
hepatic IRI. Reduced hepatic IRI was displayed by lowered serum
LDH, ALT, AST, TTC staining and cytokine levels in the serum
and the injured liver tissue, as well as reduced neutrophil
infiltration and activity in the injured liver. Since LDH, ALT,
AST are surrogate parameters for liver damage we only can
speculate if our results are due to reduced tissue damage via
diminished p-53 signalling or altered migration and adhesion
properties of neutrophils. Furthermore, the crucial differences
between our and other studies employing anti-UNC5B antibodies
are the time-point, the way of the antibody administration and
the dose used. We perfomed i.v. injection of the anti-UNC5B
antibody 15 minutes prior to surgical procedures. The dose was
5 mg/mouse (200 mg/kg body weight). In the study of Tadagavadi
et al. [17] the UNC5B blocking antibody was injected i.p.
18 hours before the induction of IRI in a dose of 800 mg/kg
body weight. Aherne et al. [26] started the i.p. administration of
the UNC5B blocking antibody 2 days before induction of DSS
colitis. The dose of the UNC5B blocking antibody in this study
was 800 mg/kg body weight. Therefore the differences in the
findings from our study to these previously published data might
be explained by the different time-point, way of administration
and dose of the UNC5B blocking antibody.
Taken together, we report here that repression and functional
inhibition of UNC5B is protective during the early phase of
hepatic IRI holds protective potential and might be a strategy in
the future to reduce tissue damage associated with reperfusion
injury.
Supporting Information
Figure S1 UNC5B
+/2 animals display altered cytokine
expression after hepatic IRI. RT-PCR was performed from
liver samples. Relative mRNA expression of A) TNF-a, B) IL-6, C)
CXCL1 and D) CXCL2 are shown. Data are mean 6 SEM, n=5
per group
(TIF)
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